Home ›
NPI 1336590413
NPI deactivated
1336590413
1336590413 was paid $172K by Medicaid between Jan 2018 and Aug 2020, across 9 billing codes. Its largest line is 86618, — 27% of everything it billed.
33Billing provider info1336590413
33aNPI1336590413
33bProvider type—
28Total paid$172K
24GClaims14,195
24DCodes billed9
24AFirst – last monthJan 2018 – Aug 2020
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 7,400 | $98K | |
| 2019 | 5,895 | $64K | |
| 2020 | 900 | $10K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 86618 | 27% | 3,397 | 3,245 | $46K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 25% | 2,472 | 2,359 | $43K |
| 86481 | 18% | 5,038 | 4,982 | $31K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 11% | 1,014 | 958 | $20K |
| 87476 | 9.9% | 967 | 924 | $17K | |
| 86617 | 5.7% | 1,132 | 1,078 | $10K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 3.1% | 54 | 54 | $5K |
| 86619 | <1% | 66 | 60 | $211.15 | |
| 86666 | <1% | 55 | 30 | $107.40 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.